web analytics

Description

LDL apheresis can be used to lower blood LDL particles in selected patients with familial hypercholesterolemia (FH).


LDL apheresis is considered when both of the following are present:

(1) the patient fails to achieve an adequate response after >= 6 months of maximum tolerated drug therapy

(2) the patient shows certain patterns of laboratory and clinical findings

 

Parameters:

(1) type of FH

(2) serum cholesterol concentration

(3) risk factors (elevated blood pressure, smoking, obesity, physical inactivity, unhealthy diet)

 

Very high risk factors:

(1) established coronary artery disease

(2) other established vascular disease

(3) diabetes

 

Type of FH

Cholesterol in mg/dL

Risk Factors

functional homozygous

LDL-C >= 300

NA

functional homozygous

non-HDL-C >= 330

NA

functional heterozygous

LDL-C >= 300

0 or 1

functional heterozygous

non-HDL-C >= 330

0 or 1

functional heterozygous

LDL-C >=200

>= 2 or high lipoprotein(a)

functional heterozygous

non-HDL-C >= 230

>= 2 or high lipoprotein(a)

functional heterozygous

LDL-C >=160

very high risk

functional heterozygous

non-HDL-C >= 190

very high risk

 

where:

• A high lipoprotein(a) concentration is >= 50 mg/dL using an isoform insensitive assay.


To read more or access our algorithms and calculators, please log in or register.